Lilly answers insulin price-hike critics with 50% off Humalog generic

4th March 2019 Uncategorised 0

Eli Lilly CEO David Ricks may have missed last week’s Senate hearing on drug prices, but he apparently received the message on rising insulin prices. Lilly is now planning a half-priced version of its big-selling insulin Humalog and once again kicked the ball to PBMs.

More: Lilly answers insulin price-hike critics with 50% off Humalog generic
Source: fierce